Tanya Gottlieb - Department of Molecular Cell Biology, The Weizmann Institute of Science

基本信息

浏览量：33

职业迁徙

个人简介

BiondVax is a publicly traded (TASE: BNDX), advanced clinical stage biotech company dedicated to improving global protection against influenza (flu), with its lead product a universal flu vaccine called M-001 designed to trigger immunity to all influenza strains, seasonal and pandemic, present and future. My role is to build international relations with potential investors, partners and the vaccine research and business community.

研究兴趣